|
Market Cap (17-May) $41,071,320 (780th) |
Close (30-Jun) $0.081 |
Volume (30-Jun) 2,818,974 |
Shortsold (13-Feb) 21,991 (0.00%) (605th) |
|
52w High $0.063 |
52w Low $0.037 |
P/E - |
EPS -0.01 |
PTX released this announcement to the ASX on 15 November 2022, 14:23. The announcement is not marked as price sensitive, and is 7 page(s) in length and 25.77kb in size.
You can view all announcements from PTX and see how they appear on a price chart on the announcements page.
At the date of this announcement, PTX was 0.122% short sold according to ASIC data. It was ranked the 465th most shorted stock on the ASX. It remains ranked 605th as of the latest reported data (13 February 2024).
| Other Recent Announcements from PTX | |
|---|---|
| Application for quotation of securities - PTX | 14 June 2023, 15:38 |
| Two PTX abstracts accepted at prestigious ISCT conference | 16 May 2023, 8:59 |
| Initial Director's Interest Notice | 15 May 2023, 14:31 |
| Application for quotation of securities - PTX | 15 November 2022, 14:23 |
| PTX Investor presentation and additional patient response | 2 November 2022, 8:35 |
| September 2022 Quarterly Update and Appendix 4C | 31 October 2022, 9:07 |
| Notice of Annual General Meeting/Proxy Form | 27 October 2022, 15:22 |
You must be logged in to post a reply.
Prescient Therapeutics 